List of insiders holdings for Xenon Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | MX Associates LLP 10% Owner |
2015-01-07 12:57:30 | 1,474,660 0 |
1,474,660 | Form 4 |
| 2 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
2023-02-13 20:20:16 | 1,271,243 0 |
1,271,243 | Form 13G |
| 3 | STEIN EVAN A. Director |
2017-02-13 09:17:32 | 443,916 0 |
443,916 | Form 13G |
| 4 | MORTIMER IAN PRESIDENT & CEO |
2025-03-13 19:33:34 | 325,000 0 |
325,000 | Form 4 |
| 5 | HOLLER FRANK A Director |
2021-06-01 16:07:31 | 143,653 1,184 |
144,837 | Form 4 |
| 6 | Von Seggern Christopher Chief Commercial Officer |
2024-03-12 18:42:52 | 100,000 0 |
100,000 | Form 4 |
| 7 | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
2025-03-13 19:31:01 | 95,000 0 |
95,000 | Form 4 |
| 8 | DiFabio Andrea Chief Legal Officer |
2025-03-13 19:30:44 | 95,000 0 |
95,000 | Form 4 |
| 9 | TARNOW MICHAEL M Director |
2021-05-20 16:18:44 | 77,942 0 |
77,942 | Form 4 |
| 10 | AZAB MOHAMMAD Director |
2023-12-20 17:04:23 | 74,225 0 |
74,225 | Form 4 |
| 11 | AYCARDI-FONSECA ERNESTO CMO |
2020-03-13 17:06:38 | 65,000 0 |
65,000 | Form 4 |
| 12 | ROBIN SHERRINGTON EVP, Strategy & Innovation |
2024-03-12 18:35:59 | 65,000 0 |
65,000 | Form 4 |
| 13 | EMPFIELD JAMES R. EVP, Drug Discovery |
2024-03-12 18:37:25 | 65,000 0 |
65,000 | Form 4 |
| 14 | CORRAINI KAREN G. Gen. Counsel & Corp. Secretary |
2015-03-19 20:52:27 | 35,000 0 |
35,000 | Form 4 |
| 15 | PATOU GARY Director |
2024-11-22 19:48:02 | 23,573 4,902 |
28,475 | Form 4 |
| 16 | PIMSTONE SIMON N. Director |
2023-06-02 17:21:14 | 18,475 0 |
18,475 | Form 4 |
| 17 | Machado Patrick Director |
2024-06-05 17:42:53 | 15,542 0 |
15,542 | Form 4 |
| 18 | Gover Justin D. Director |
2024-06-05 17:42:40 | 15,542 0 |
15,542 | Form 4 |
| 19 | GAROFALO ELIZABETH A. Director |
2024-06-05 17:42:24 | 15,542 0 |
15,542 | Form 4 |
| 20 | Svoronos Dawn Director |
2024-06-05 17:41:36 | 15,542 0 |
15,542 | Form 4 |
| 21 | Cannon Gillian Director |
2024-06-05 17:41:52 | 15,542 0 |
15,542 | Form 4 |
| 22 | GANNON STEVEN Director |
2024-06-05 17:42:11 | 15,542 0 |
15,542 | Form 4 |
| 23 | SCHELLER RICHARD H Director |
2019-09-18 19:39:09 | 15,000 0 |
15,000 | Form 4 |
| 24 | GOLDBERG Y. PAUL SVP, Clinical Development |
2017-10-24 18:45:32 | 11,000 0 |
11,000 | Form 4 |
| 25 | Hayden Michael R Director |
2021-06-03 21:07:48 | 10,000 0 |
10,000 | Form 4 |
| 26 | Desjardins Clarissa Director |
2020-06-02 16:58:08 | 10,000 0 |
10,000 | Form 4 |
| 27 | COHEN CHARLES J. VP, Biology |
2018-12-13 13:56:50 | 6,550 0 |
6,550 | Form 4 |
| 28 | AULIN SHERRY Chief Financial Officer |
2024-12-19 18:57:42 | 6,000 0 |
6,000 | Form 4 |
| 29 | Bridger Gary EVP, Research & Development |
2014-11-25 21:20:38 | 5,144 0 |
5,144 | Form 4 |
| 30 | Evans Johnston L Director |
2015-05-06 15:46:21 | 3,086 0 |
3,086 | Form 4 |
| 31 | WINQUIST RAYMOND Head, Translational Research |
2017-08-21 16:48:27 | 1000 0 |
1000 | Form 4 |